share_log

Ocumension Gets Clearance to Start Phase III Study in China of Diabetic Macular Edema Drug

Ocumension Gets Clearance to Start Phase III Study in China of Diabetic Macular Edema Drug

Ocumation獲準在中國啟動糖尿病黃斑水腫藥物的第三階段研究
MT Newswires ·  2022/06/10 05:34

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論